New Report Just Published: World Prostate Cancer Therapeutics Market Report
...630 in Patients with Prostate Cancer II-54 ambrilia Unveils Results of PCK3145 in Patients with Me...fer Better Results for HRPC Patients II-58 ambrilia Reveals Results of PSP-94 Immunoassay Study for ...ths Due to Prostate Cancer by Age Group III-69 ambrilia Unveils Results of PCK3145 in Patients with Me...Ambrilia Biopharma Inc. - Information & Fact Sheet - Hoover's
Ambrilia Biopharma likes to work with drug candidates when they're still in the early stages of development. Once they hit late stage, the company prefers to license...AMB,AMBFF,MRK Ambrilia Biopharma Submits a Request for Arbitration ...
TradingMarkets News for AMB,AMBFF,MRK - Ambrilia Biopharma Submits a Request for Arbitration Against Merck ... In October 2006, Ambrilia entered into an ...News: Ambrilia Biopharma Submits a Request for Arbitration Against Merck.
Ambrilia Biopharma Inc. (TSX: AMB) announced today that it has submitted a Request for Arbitration with the International Chamber of Commerce (ICC) to resolve ...UPDATE 1-Ambrilia sells prostate cancer drug candidate | Industries ...
July 16 (Reuters) - Small Canadian biotech company Ambrilia Biopharma Inc <AMB.TO> said it agreed to sell its experimental prostate cancer drug, PCK3145, to Kotinos ...Ambrilia Announces Change to Its Board of Directors | Reuters
MONTREAL, QUEBEC, Aug 14 (MARKET WIRE) -- Ambrilia Biopharma Inc. ... On July 31, 2009, Ambrilia received protection under an initial order granted ...